Side Effect Management
Blood Test Results May Offer Clues to Neurotoxicity Risk After CAR-T Cell Therapy in Cancer
September 22nd 2022Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.